PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
Cathepsin G 1,613 Target Disease Urticaria 10,717 4 0.00 -1.00 0.00 0.58
Cathepsin G 1,613 Target Disease Mesothelioma 11,198 1 0.00 -1.00 0.00 0.54
Cathepsin G 1,613 Target Disease Glioblastoma 17,933 1 0.00 -1.00 0.00 0.53
DC-CK1 22 Target Disease Hepatitis 163,842 1 0.00 -0.98 0.05 0.56
Cathepsin G 1,613 Target Disease Malnutrition 27,452 1 0.00 -1.00 0.00 0.52
Cathepsin G 1,613 Target Disease Heart Disease 118,291 4 0.00 -1.00 0.00 0.52
Cathepsin G 1,613 Target Disease Liver Disease 49,817 5 0.00 -1.00 0.00 0.55
Cathepsin G 1,613 Target Disease Inflammation 252,734 207 0.01 -0.93 0.13 0.61
Cathepsin G 1,613 Target Drug Doxycycline 9,324 4 0.00 -1.00 0.00 0.59
Cathepsin G 1,613 Target Disease Ulcers 45,142 2 0.00 -1.00 0.00 0.52
Cathepsin G 1,613 Target Disease Inflammatory Bowel Diseases 4,684 5 0.00 -1.00 0.00 0.62
Cathepsin G 1,613 Target Target Elastase 13,875 985 0.21 -0.60 0.61 0.81
Cathepsin G 1,613 Target Target CD34 24,598 13 0.00 -1.00 0.01 0.59
Cathepsin G 1,613 Target Target CXCL2 750 6 0.01 -0.99 0.01 0.68
Eotaxin 2,457 Target Target CA 15-3 898 2 0.00 -1.00 0.00 0.62
DC-CK1 22 Target Target CXCL9 1,016 1 0.01 -0.98 0.05 0.69
DC-CK1 22 Target Target CCL3 1,427 1 0.01 -0.98 0.05 0.68
Aldosterone Receptor 528 Target Disease Diabetic Nephropathy 12,496 14 0.01 -0.99 0.03 0.64
Aldosterone Receptor 528 Target Disease Sleep Apnea 18,342 4 0.00 -1.00 0.01 0.59
Aldosterone Receptor 528 Target Disease Renal Failure 73,993 16 0.00 -0.98 0.03 0.59
Aldosterone Receptor 528 Target Disease Shock 134,031 2 0.00 -1.00 0.00 0.52
Aldosterone Receptor 528 Target Target BNP 6,842 5 0.00 -0.99 0.01 0.63
Aldosterone Receptor 528 Target Disease Ventricular Dysfunction 12,856 31 0.01 -0.97 0.06 0.67
Aldosterone Receptor 528 Target Target ERK1 18,374 4 0.00 -1.00 0.01 0.59
Aldosterone Receptor 528 Target Disease Glomerulonephritis 23,459 3 0.00 -1.00 0.01 0.58
DC-CK1 22 Target Disease Malaria 56,215 1 0.00 -0.98 0.05 0.58
Aldosterone Receptor 528 Target Disease Gynecomastia 2,594 16 0.01 -0.98 0.03 0.70
Aldosterone Receptor 528 Target Disease Stroke 146,992 16 0.00 -0.98 0.03 0.57
DC-CK1 22 Target Target CXCL2 750 1 0.01 -0.98 0.05 0.70
DC-CK1 22 Target Disease Inflammation 252,734 2 0.00 -0.95 0.09 0.57
DC-CK1 22 Target Disease Septic Arthritis 4,121 1 0.00 -0.98 0.05 0.65
DC-CK1 22 Target Target CXCL10 2,386 1 0.00 -0.98 0.05 0.66
DC-CK1 22 Target Target CD34 24,598 1 0.00 -0.98 0.05 0.60
DC-CK1 22 Target Target CXCL3 145 1 0.02 -0.97 0.05 0.75
DC-CK1 22 Target Target CXCL11 526 1 0.01 -0.98 0.05 0.71
Aldosterone Receptor 528 Target Disease Dyspnea 24,781 3 0.00 -1.00 0.01 0.57
Trace Amine-Associated Receptor 1 64 Target Disease Hyperglycemia 28,168 1 0.00 -0.99 0.02 0.58
BMP-2B 18 Target Target Activin A 2,048 1 0.01 -0.97 0.06 0.67
BMP-2B 18 Target Target BMP-2 3,889 3 0.01 -0.91 0.17 0.68
Erbb2 4,536 Target Disease Ventricular Dysfunction 12,856 8 0.00 -1.00 0.00 0.58
Erbb2 4,536 Target Target Insulin-Like Growth Factor 1 Receptor 1,052 12 0.01 -0.99 0.01 0.66
Erbb2 4,536 Target Disease Influenza 67,933 2 0.00 -1.00 0.00 0.49
Erbb2 4,536 Target Target Adiponectin 11,994 4 0.00 -1.00 0.00 0.56
Erbb2 4,536 Target Target AFP 9,751 5 0.00 -1.00 0.00 0.57
Erbb2 4,536 Target Target ERK1 18,374 111 0.01 -0.98 0.02 0.66
Erbb2 4,536 Target Target ETS1 539 4 0.00 -1.00 0.01 0.63
Erbb2 4,536 Target Disease Basal Cell Carcinoma 7,953 2 0.00 -1.00 0.00 0.55
Erbb2 4,536 Target Disease Gynecomastia 2,594 1 0.00 -1.00 0.00 0.56
Erbb2 4,536 Target Disease Osteoporosis 46,215 2 0.00 -1.00 0.00 0.50
Erbb2 4,536 Target Target ANGPTL4 289 1 0.00 -1.00 0.00 0.60
Erbb2 4,536 Target Target CCL5 2,002 2 0.00 -1.00 0.00 0.58
Erbb2 4,536 Target Disease Gastroesophageal Reflux Disease 7,437 2 0.00 -1.00 0.00 0.55
Erbb2 4,536 Target Disease Lung Carcinoma 13,423 25 0.00 -1.00 0.01 0.61
Erbb2 4,536 Target Target Steroid 5-Alpha-Reductase 293 1 0.00 -1.00 0.00 0.60
Erbb2 4,536 Target Disease Multiple Myeloma 24,594 4 0.00 -1.00 0.00 0.53
Erbb2 4,536 Target Target AKT3 293 10 0.01 -0.98 0.03 0.68
Erbb2 4,536 Target Target BNP 6,842 3 0.00 -1.00 0.00 0.56
Erbb2 4,536 Target Target Chorionic Gonadotropin beta 936 1 0.00 -1.00 0.00 0.58
Erbb2 4,536 Target Target EPHA2 532 6 0.00 -0.99 0.01 0.65
Erbb2 4,536 Target Target Phospholipase A2 13,400 1 0.00 -1.00 0.00 0.51
Erbb2 4,536 Target Target ERK2 3,287 16 0.00 -1.00 0.00 0.65
Erbb2 4,536 Target Drug Droloxifene 123 1 0.00 -1.00 0.01 0.62
Erbb2 4,536 Target Disease Celiac Disease 8,026 1 0.00 -1.00 0.00 0.53
Erbb2 4,536 Target Target Urokinase-Type Plasminogen Activator 3,939 11 0.00 -1.00 0.00 0.63
Erbb2 4,536 Target Disease Headache 50,687 1 0.00 -1.00 0.00 0.48
Erbb2 4,536 Target Target Ricin 3,034 1 0.00 -1.00 0.00 0.55
Erbb2 4,536 Target Target BMX 185 1 0.00 -1.00 0.01 0.61
Erbb2 4,536 Target Target Annexin A1 406 1 0.00 -1.00 0.00 0.60
Erbb2 4,536 Target Disease Dyspnea 24,781 3 0.00 -1.00 0.00 0.53
Erbb2 4,536 Target Target Tissue-Type Plasminogen Activator 5,020 5 0.00 -1.00 0.00 0.59
Erbb2 4,536 Target Disease Anemia 81,663 3 0.00 -1.00 0.00 0.49
Erbb2 4,536 Target Disease Arthritis 128,324 6 0.00 -1.00 0.00 0.50
Erbb2 4,536 Target Disease Sleep Apnea 18,342 1 0.00 -1.00 0.00 0.50
Erbb2 4,536 Target Target Methylenetetrahydrofolate Reductase 3,573 3 0.00 -1.00 0.00 0.58
Erbb2 4,536 Target Target EPHB3 118 2 0.00 -0.99 0.02 0.64
Erbb2 4,536 Target Disease Renal Failure 73,993 1 0.00 -1.00 0.00 0.47
Erbb2 4,536 Target Disease Shock 134,031 70 0.00 -0.99 0.02 0.57
Erbb2 4,536 Target Target CA 15-3 898 4 0.00 -1.00 0.00 0.62
Erbb2 4,536 Target Disease Benign Prostatic Hyperplasia 10,026 7 0.00 -1.00 0.00 0.58
Erbb2 4,536 Target Disease Sentinel Lymph Node Biopsy 3,064 4 0.00 -1.00 0.00 0.60
Erbb2 4,536 Target Disease Stroke 146,992 1 0.00 -1.00 0.00 0.46
Erbb2 4,536 Target Disease Hepatitis B 57,815 4 0.00 -1.00 0.00 0.51
Des (1-3) IGF-I 191 Target Disease Inflammatory Bowel Diseases 4,684 1 0.00 -1.00 0.01 0.61
Des (1-3) IGF-I 191 Target Disease Lung Cancer 91,416 1 0.00 -1.00 0.01 0.54
Des (1-3) IGF-I 191 Target Target bFGF 9,327 2 0.00 -0.99 0.01 0.61
Des (1-3) IGF-I 191 Target Disease Breast Cancer 173,695 7 0.00 -0.98 0.04 0.57
Des (1-3) IGF-I 191 Target Disease Diabetic Retinopathy 14,494 1 0.00 -1.00 0.01 0.58
Des (1-3) IGF-I 191 Target Disease Dementia 66,782 1 0.00 -1.00 0.01 0.54
Des (1-3) IGF-I 191 Target Target EGF 27,487 7 0.00 -0.98 0.04 0.61
Des (1-3) IGF-I 191 Target Target Platelet Activating Factor 9,915 1 0.00 -1.00 0.01 0.59
Des (1-3) IGF-I 191 Target Target Collagen 138,882 9 0.00 -0.98 0.05 0.58
Des (1-3) IGF-I 191 Target Target BMP-7 1,112 1 0.00 -1.00 0.01 0.65
Des (1-3) IGF-I 191 Target Target Dihydrofolate Reductase 5,563 1 0.00 -1.00 0.01 0.60
Des (1-3) IGF-I 191 Target Disease Benign Prostatic Hyperplasia 10,026 1 0.00 -1.00 0.01 0.59
Des (1-3) IGF-I 191 Target Target Des (1-6) IGF-II 18 5 0.09 -0.84 0.28 0.81
Des (1-3) IGF-I 191 Target Disease Renal Failure 73,993 4 0.00 -0.99 0.02 0.57
Des (1-3) IGF-I 191 Target Disease Hyperglycemia 28,168 2 0.00 -0.99 0.01 0.58
Des (1-3) IGF-I 191 Target Disease Prostate Cancer 71,064 1 0.00 -1.00 0.01 0.54
AMY2B 21 Target Target Pancreatic Alpha-Amylase 423 3 0.03 -0.92 0.14 0.76
Des (1-3) IGF-I 191 Target Disease Inflammation 252,734 1 0.00 -1.00 0.01 0.51